Mechanism of Glycosaminoglycan-Mediated Bone and Joint Disease
Calogera M. Simonaro(Icahn School of Medicine at Mount Sinai), Edward H. Schuchman(Icahn School of Medicine at Mount Sinai), Mark E. Haskins(University of Pennsylvania), Marina D’Angelo(Philadelphia College of Osteopathic Medicine), Xingxuan He(Icahn School of Medicine at Mount Sinai), Efrat Eliyahu(Icahn School of Medicine at Mount Sinai), Nataly Shtraizent(Icahn School of Medicine at Mount Sinai)
Cited by 206
Related Papers
Niemann-Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium
|Nature Medicine|2008|833
Acid Sphingomyelinase–Deficient Human Lymphoblasts and Mice Are Defective in Radiation-Induced Apoptosis
|Cell|1996|797
Oocyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphingosine -1-phosphate therapy
|Nature Medicine|2000|596
Acid sphingomyelinase activity triggers microparticle release from glial cells
|The EMBO Journal|2009|586